Novel Patented Technology​
The Smart Solution for Prescription Drug Abuse

ZICOH® Patents

CountryTitlePatent Status
United States

Secure Smart Dosing System With Automated Delivery, Measurement, and Management

Granted, 2021
United States

Smart Inhaler Device With Automated Dose Delivery, Measurement, and Management

Granted, 2021
Patented Technology

TABMELT

Novel Patented Technology to Make Blockbuster Medications Better

TABMELT® Patents

CountryCompoundPatent Status
United StatesVVRA – TM 001: Cardiovascular drugApplication Filed
United StatesVVRA – TM 002: CNS drugApplication Filed
United StatesVVRA – TM 003: CNS drugApplication Filed
United StatesVVRA – TM 004: CNS combinationApplication Filed
United StatesVVRA – TM 005: CNS drugApplication Filed
United StatesPTNR – TM 006: CNS drugApplication Filed
United StatesPTNR – TM 007: CNS drugApplication Filed
United StatesVVRA – TM 008: CNS drugFiling Application

Licensed Patents

CountryTitlePatent Status
AustraliaAll Natural, Non-Toxic Sublingual Drug Delivery SystemsGranted, 2016
CanadaAll Natural, Non-Toxic Sublingual Drug Delivery SystemsGranted, 2018
Great BritainAll Natural, Non-Toxic Sublingual Drug Delivery SystemsGranted, 2018
RussiaAll Natural, Non-Toxic Sublingual Drug Delivery SystemsGranted, 2021
IsraelAll Natural, Non-Toxic Sublingual Drug Delivery SystemsApplication Filed
JapanAll Natural, Non-Toxic Sublingual Drug Delivery SystemsApplication Filed
MexicoAll Natural, Non-Toxic Sublingual Drug Delivery SystemsApplication Filed
United StatesAll Natural, Non-Toxic Sublingual Drug Delivery SystemsApplication Filed

SCIENTIFIC LEADS

Dr. McColgan

Stephen J. McColgan, M.D. M.B.A.

Chief Medical Officer
  • 68 invited presentations, 12 publications
  • 35 years of surgical experience, 30+ years of experience in medical & surgical device development
  • Developed enhanced laparoscopic devices for a medical technology company, driving acquisition by a major publicly-traded company
  • Clinical instructor, professional consultant
  • Currently developing ZICOH and endomechanical devices for cardiovascular medicine and surgery
Don-D'Ambrosio (1)

Don D'Ambrosio

Chief Financial Officer
  • Four decades of experience serving in executive and officer roles within banking, investment, and finance firms
  • Nominated twice by the Orange County Business Journal as "CFO of the Year" for his work at MYnd Analytics, where he led the Company's public raise and completed the MYnd uplisting to the Nasdaq Exchange
  • Bachelor of Business Administration degree with an emphasis in accounting from Temple University
Dr. Maguire

Gerald A Maguire, M.D., D.F.A.P.A.

Chief Advisor, Neurosciences Division
  • Person who stutters and subject matter expert
  • 76 publications on stuttering—the most published doctor in the space
  • PI for the first investigational drug for stuttering in adults
  • Hundreds of invited presentations on stuttering
  • Professor of psychiatry, clinical trialist (PI of 40+ clinical trials for 25+ years)
  • Chair of R&D for World Stuttering Network
Mehdi-Hatamian3264-1024x869

Mehdi Hatamian, Ph.D.

Senior Scientific Advisor
  • 97 patents issued, 50 publications
  • 40+ years of engineering experience in the electrical and biomedical spaces
  • Chief Scientist of Central Engineering at Broadcom with a 20-year tenure
  • Former program engineer for the NASA Space Shuttle
  • Member of the National Academy of Engineering
  • Currently developing ZICOH and nextgeneration cancer detection devices and technologies
Bobby W. Sandage

Bobby W. Sandage, Jr., Ph.D.

Advisory Board
  • 3 patents issued, 50+ scientific articles 
  • 35+ years of experience in drug development, regulatory affairs, & life sciences venture capital 
  • Guided development for 35 products/programs
  • Achieved regulatory approval for 12 drugs and 1 device
  • Adjunct professor of pharmaceutical sciences
  • Drug Development Institute advisor for the Ohio State University Comprehensive Cancer Center
Kheriaty-2-1

Aaron Kheriaty, M.D.

Medical Ethics Advisor
  • 15 years of experience as a psychiatrist
  • Chairman of the medical ethics committee at the CA Department of State Hospitals
  • Professor of Psychiatry at the University of California, Irvine School of Medicine and Director of the Medical Ethics Program at UCI Health
  • Published in the Wall Street Journal and the Washington Post
  • Authored books and articles for professional and lay audiences on bioethics, social science, psychiatry, religion, and culture
Alan Poleszak[3434]

Alan Poleszak

Advisory Board, Government Affairs
  • 23 years of experience as a decorated U.S. Department of Justice, Drug Enforcement Administration (DEA) Special Agent Executive
  • Nearly 40 years of federal, state, local, and international law enforcement, investigative, and defense experience in Government and in the private sector
  • Developed international, national, and regional counter drug, pharmaceutical diversion, and general crimes strategies with government executives, community leaders, private industry officials, and the U.S. Military

Contact Us

Fill out the form below, and a member of our team will reach out to you shortly.

About Vivera

Vivera Pharmaceuticals is an innovative, science-driven pharmaceutical company located in Southern California. The Company has global exclusivity to license the patented and patent-pending TABMELT® sublingual drug delivery system for pharmaceutical use and owns its own patents on ZICOH®, a controlled medication dispensing device. Vivera Pharmaceuticals is vertically integrated with patented technology, manufacturing capabilities, and distribution for its products.